指南与共识泌尿生殖技术与安全MR

用于活检初治男性前列腺癌MRI检测的人工智能开发与报告要求:PI-RADS指导委员会版本1.0

Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0.
PubMed 文献 · Radiology · 2025-01-01

本文由PI-RADS指导委员会制定,针对临床筛查阳性且未经活检的男性,规范了基于MRI检测临床显著前列腺癌的人工智能解读模型的开发与报告要求。文件提出了数据要求、性能指标范围(如PI-RADS≥4病灶的癌症检出率40%-70%)、真阴性检查定义(至少随访2年)及报告清单,鼓励使用开放数据集并遵循CLAIM清单。

要点

  • AI模型开发需明确训练与测试数据的透明性和特征描述。
  • 真阴性检查定义要求至少2年随访,并需评估图像质量。
  • 性能指标需展示ROC和精确率-召回率曲线,且不劣于人类表现。

核心结论

  • 本文为前列腺MRI人工智能解读模型的开发与报告提供了基于亚专科专业知识的指导,旨在加速AI在前列腺癌检测中的临床转化。

研究设计与样本

  • PI-RADS指导委员会制定的指导性文件,基于亚专科专业知识,未报告系统检索方法或证据分级。

诊断标准与关键数值

  • PI-RADS 4或更高病灶的癌症检出率范围为40%-70%。
  • 真阴性检查定义要求至少2年随访。
  • 需使用受试者工作特征曲线和精确率-召回率曲线证明AI性能等于或优于人类表现。
  • 研究设计应符合医学影像人工智能清单(Checklist for Artificial Intelligence in Medical Imaging)要求。

临床应用与阅片要点

  • 开发AI模型时需提供训练和测试数据的充分信息以确保透明性和特征描述。
  • 需进行图像质量评估并纳入非影像元数据要求。
  • 鼓励使用开放数据集,如AI挑战赛模型中所用的数据集。
  • 本文应结合当前和不断演变的监管环境来理解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This document defines the key considerations for developing and reporting an artificial intelligence (AI) interpretation model for the detection of clinically significant prostate cancer (PCa) at MRI in biopsy-naive men with a positive clinical screening status. Specific data and performance metric requirements and a checklist are provided for this use case. Data requirements emphasize the need for sufficient information to provide transparency and characterization of training and test data. The definition of a true-negative examination (which includes a minimum of 2-year follow-up), the need for image quality assessments, and nonimaging metadata requirements are provided. Performance metrics ranges are included, such as a cancer detection rate of 40%-70% for Prostate Imaging Reporting and Data System, or PI-RADS, 4 or higher lesions and demonstration of equivalent or better than human performance using receiver operating characteristic and precision-recall curves. The use of open datasets such as those used in the AI challenge model is encouraged. The study design should include conformity with the Checklist for Artificial Intelligence in Medical Imaging requirements. This article should be taken in the context of the current and evolving regulatory landscape. This review provides guidance based on subspeciality expertise in prostate MRI and will hopefully accelerate the clinical translation of AI in PCa detection.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Turkbey B, Huisman H, Fedorov A, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0. Radiology. 2025. PMID: 40232134. doi:10.1148/radiol.240140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。